8-K: FOXO Technologies Authorizes New Series of Preferred Stock to Bolster Capital Structure
Corporate Action
FOXO Technologies Inc. has filed amendments to its Certificate of Incorporation to authorize the issuance of Series B and Series C Preferred Stock, establishing their rights, preferences, and limitations.
Summary
- FOXO Technologies has created two new series of preferred stock, Series B and Series C, by filing amendments to its Certificate of Incorporation on November 27, 2024.
- The company is authorized to issue up to 7,500 shares of Series B Preferred Stock and 5,000 shares of Series C Preferred Stock.
- Both series of preferred stock have a par value of $0.0001 per share.
- The Board of Directors has the authority to establish the rights, preferences, and limitations of these new series.
- Holders of both Series B and Series C Preferred Stock have voting rights, with each share having one vote, but are subject to a 19.99% voting cap prior to stockholder approval.
- Both series of preferred stock are entitled to cumulative cash dividends, payable quarterly in arrears starting March 15, 2025.
- Dividends are calculated based on a 360-day year and accrue daily from the original issue date.
- In the event of liquidation, holders of both series of preferred stock will receive distributions pro rata with other common stock equivalents after any senior securities are paid.
- Series B Preferred Stock has staggered conversion dates, with the earliest conversion possible one year after the original issue date.
- Series C Preferred Stock can be converted six months after the original issue date or upon the effectiveness of a registration statement covering the resale of conversion shares.
- The conversion price for both series is the higher of a fixed price ($0.05 for Series B, $0.03 for Series C) or 90% of the average VWAP for the five trading days prior to the conversion date.
Sentiment
Score: 6
Explanation: The document is neutral to slightly positive. The creation of new preferred stock is a common financial maneuver, but the terms are not overly favorable or unfavorable. The potential for dilution is a concern, but the capital raise is a positive for the company's financial position.
Positives
- The creation of new preferred stock series provides FOXO Technologies with additional financial flexibility.
- The cumulative dividend feature of the preferred stock may attract investors seeking regular income.
- The conversion rights offer potential upside for investors if the company's stock price appreciates.
- The staggered conversion dates for Series B Preferred Stock may provide a more controlled approach to potential dilution.
Negatives
- The issuance of preferred stock could potentially dilute existing common shareholders.
- The 19.99% voting cap on the preferred stock prior to stockholder approval limits the influence of preferred shareholders.
- The conversion price is subject to a floor, which could limit the potential upside for preferred shareholders if the stock price does not perform well.
- The staggered conversion dates for Series B Preferred Stock may create uncertainty for investors.
Risks
- The company's ability to pay dividends on the preferred stock is dependent on its financial performance.
- The conversion of preferred stock into common stock could lead to dilution of existing shareholders.
- The market price of the common stock could be volatile, impacting the value of the preferred stock.
- The company's ability to achieve the goals that require this capital raise is not guaranteed.
Future Outlook
The document does not contain specific forward-looking statements beyond the mechanics of the preferred stock issuance and conversion.
Management Comments
- The Board authorized the Series B Preferred Stock and the Series C Preferred Stock pursuant to the authority given to the Board under the Certificate of Incorporation.
Industry Context
The issuance of preferred stock is a common method for companies to raise capital and manage their capital structure, particularly for growth-oriented companies. This move suggests FOXO is seeking to strengthen its financial position.
Comparison to Industry Standards
- The use of convertible preferred stock is a common practice among companies seeking to raise capital, particularly in the technology and biotech sectors.
- The specific terms of the conversion, such as the floor price and the VWAP calculation, are typical in these types of financings.
- The staggered conversion dates for Series B are less common, but may be used to manage potential dilution.
- Companies like Amyris, Inc. and Sorrento Therapeutics, Inc. have used similar structures in the past to raise capital.
Stakeholder Impact
- Shareholders may experience dilution if the preferred stock is converted to common stock.
- Preferred shareholders will receive dividends and have potential upside through conversion.
- The capital raise may improve the company's financial stability, which could benefit employees and other stakeholders.
Next Steps
- The company will need to issue the preferred stock.
- The company will need to manage the conversion of the preferred stock into common stock.
- The company will need to pay dividends on the preferred stock.
Key Dates
| Date | Description |
|---|---|
| November 27, 2024 | Date of filing amendments to the Certificate of Incorporation and authorization of Series B and Series C Preferred Stock. |
| December 4, 2024 | Date of report signature by Mark White, Interim Chief Executive Officer. |
| March 15, 2025 | First dividend payment date for both Series B and Series C Preferred Stock. |
Keywords
Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Convertible Stock, Dividends, Voting Rights, Liquidation Preference, Conversion Rights, Capital Structure, Corporate Finance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.